The study included 10,346 children with overweight or obesity but without T2D at baseline (median age, 12.5 years; 43.1% girls; 1102 with MASLD) and 59,336 matched control individuals from the ...

New recommendations suggest holding back on SGLT2 inhibitors and GLP-1s among those at a lower risk for cardiovascular or ...

WEDNESDAY, June 25, 2025 (HealthDay News) -- For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss ...

The current multicenter observational cohort consisted of pregnant individuals with T2D who delivered from January 2021-April 2024. The study took place at 192 hospitals in 38 states. Data were ...

This was evidenced in selected patients with T2D and moderate cardiovascular risk -- already on metformin and free of certain comorbidities -- in whom the risk of major adverse cardiovascular ...